ReviewChemical reviews2026
Computational Mass Spectrometry Imaging in the Era of AI.
Review in Chemical reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Mass spectrometry imaging (MSI) is a tool-of-choice for mapping and understanding the spatial organization of biomolecules, including small metabolites, lipids, peptides, and many others. As the MSI instrument and spatial biology inquiries evolve, researchers and practitioners are constrained by the inherent trade-offs in spatial resolution, chemical detail, and acquisition time. Here, we review how the rapidly growing interplay between MSI and machine learning/artificial intelligence (ML/AI)-powered computational approaches is addressing these issues. We begin by highlighting key steps in MSI experiments and summarizing major ML/AI paradigms in the context of MSI data, providing a foundation to review how ML/AI impact each step in the MSI workflow, starting with methods to accelerate data acquisition. We then discuss emerging applications of dimensionality reduction, segmentation, and various supervised/unsupervised learning approaches to extract useful chemical insights from high-dimensional MSI data. Approaches to leverage multimodal imaging to guide the acquisition process or provide a more informative integrated analysis are discussed. We conclude with a forward-looking discussion on the state of computation and MSI, spanning ML-enabled instrumentation, scaling measurements to 3D and large cohorts, and the integration of MSI with other spatial omic data.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.